BioInformant

Your Global Leader in Stem Cell Market Research

Home » Stem Cells » HSCs

Hematopoietic Stem Cells (HSCs)

Cord Blood Industry Consolidation Escalates as 2020 Approaches

By 2 Comments

The global cord blood industry experienced strong growth from the early 1990’s through the mid 2000’s, during which time more than 450 cord blood banking companies emerged worldwide. Approximately half of those companies owned their own labs, while the others were marketing entities or sub-contractors of storage space.

Starting about ten years ago, the market suddenly changed course. It entered a period of aggressive consolidation.

Over the past decade, the cord blood industry has witnessed substantial consolidation, particularly within the United States, Europe, and Latin America.

With CBR’s recent acquisition of Natera’s Evercord™ Cord Blood Business on September 13, 2019, the trend of cord blood industry consolidation continues. [Read more…]

Stem Cell Therapy as Hemophilia Treatment

By

Traditionally, hemophilia treatment has leveraged injections of a clotting factor or plasma. Learn more about how stem cells may hold promise for treating hemophilia using a cellular approach.

In this article:

  1. What Is Hemophilia?
  2. What Are the Causes of Hemophilia?
  3. Is Hemophilia Life-Threatening?
  4. How Does Embryonic Stem Cell Transplant Work with Hemophilia Treatment?
  5. Do Bone Marrow Stem Cells Contribute to Hemophilia Treatment?

[Read more…]

How to Find a Stem Cell Clinical Trial for Your Condition

By

Stem cell clinical trials are research studies that involves human patients. Learn a simple tool to identify stem cell clinical trials for your condition.

Are you or a loved on suffering from arthritis, multiple sclerosis (MS), COPD, Alzheimer’s disease, asthma, or other chronic condition? If so, how do you find a stem cell clinical trial?

This article provides the answers, including links to find a clinical trials near you, as well as links to clinical trials for specific conditions. 

[Read more…]

Cord Blood Market Consolidation in Latin America

By

CryoHoldcoIn this interview with James Alexis Mendez, we discuss the market strategy of CryoHoldco, a stem cell bank holding company that is the market leader in Latin America and one of the ten largest cord blood banks in the world. James Alexis Mendez currently serves as the CFO and Board member of CryoHoldco.

Approaching 200,000 stem cell units in storage, CryoHoldco is more than 5X larger than any other stem cell bank in Latin America.

CryoHoldco owns the cord blood market leaders in both Mexico and Colombia, and plans to expand into other regions of Latin America. In this interview, we discuss the current and future state of cord blood banking within Latin America, Cryoholdco’s role within this evolving marketplace, and future directions for the company.

Prior to initiating the consolidation strategy of CryoHoldco with ACON Investments, Alexis was a Director of TCP Latam, a private equity and restructuring fund in Brazil.  Prior to TCP Latam, he was a senior associate at Long Point Capital, a leveraged-buyout private equity fund in New York, where Alexis was responsible for equity investments in excess of USD $100 million in several private companies.

[Read more…]

Gamida Cell, President Dr. Yael Margolin Reveals the Unmet Need in HSCT

By

Dr. Yael Margolin, CEO of Gamida Cell
Dr. Yael Margolin, President of Gamida Cell

Gamida Cell is a cell therapy company that is best known for its innovative approaches to hematopoietic stem cell transplantation (HSCT). Headquartered in Jerusalem, Israel, Gamida Cell has been advancing several clinical programs using ex vivo expanded hematopoietic stem cells (HSCs) created using its proprietary nicotinamide (NAM) technology.

I had the honor of interviewing Dr. Yael Margolin, President of Gamida Cell. In this interview, we discuss how Gamida Cell is using cell therapeutics to address the unmet need in hematopoietic stem cell transplantation (HSCT). [Read more…]

BioInformant's World-Class Clients